市場調査レポート
商品コード
1111262

ニュートリゲノミクスの世界市場:2022年~2026年

Global Nutrigenomics Market 2022-2026

出版日: | 発行: TechNavio | ページ情報: 英文 120 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
ニュートリゲノミクスの世界市場:2022年~2026年
出版日: 2022年08月02日
発行: TechNavio
ページ情報: 英文 120 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のニュートリゲノミクスの市場規模は、2022年から2026年の間に6億9,014万米ドル成長し、予測期間中は12.4%のCAGRで成長する見込みです。

同市場は、医療費の増加、政府および民間の利害関係者からの投資拡大、健康志向の高まりなどに牽引されています。

当レポートでは、ニュートリゲノミクスの世界市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、および約25のベンダーをカバーする分析を提供しています。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 市場情勢

  • 市場のエコシステム

第3章 市場規模

  • 市場の定義
  • 市場セグメント分析
  • 2021年の市場規模
  • 市場の見通し:2021年から2026年の予測

第4章 ファイブフォース分析

  • ファイブフォースまとめ
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

第5章 市場セグメンテーション:用途別

  • 市場セグメント
  • 用途別の比較
  • 肥満:市場規模と予測(2021年~2026年)
  • 心血管疾患:市場規模と予測(2021年~2026年)
  • 癌研究:市場規模と予測(2021年~2026年)
  • 用途別の市場機会

第6章 顧客情勢

  • 顧客情勢の概要

第7章 地域別情勢

  • 地域別セグメンテーション
  • 地域別の比較
  • 北米:市場規模と予測(2021年~2026年)
  • 欧州:市場規模と予測(2021年~2026年)
  • アジア:市場規模と予測(2021年~2026年)
  • その他の地域:市場規模と予測(2021年~2026年)
  • 米国:市場規模と予測(2021年~2026年)
  • ドイツ:市場規模と予測(2021年~2026年)
  • 英国:市場規模と予測(2021年~2026年)
  • フランス:市場規模と予測(2021年~2026年)
  • カナダ:市場規模と予測(2021年~2026年)
  • 地域情勢別の市場機会

第8章 推進要因、課題、および動向

  • 市場推進要因
  • 市場の課題
  • 推進要因と課題の影響
  • 市場動向

第9章 ベンダー情勢

  • 概要
  • ベンダー情勢
  • 混乱の状況
  • 業界のリスク

第10章 ベンダー分析

  • 対象ベンダー
  • ベンダーの市場ポジショニング
  • Cell Logic Pty Ltd
  • Cura Integrative Medicine
  • DNA Life
  • Fagron NV
  • Genova Diagnostics Inc.
  • Holistic Health International LLC
  • Metagenics Inc.
  • Nutrigenomix Inc.
  • The Gene Box
  • Xcode Life Sciences Pvt. Ltd

第11章 付録

図表

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Application
  • Exhibits6: Executive Summary - Chart on Incremental Growth
  • Exhibits7: Executive Summary - Data Table on Incremental Growth
  • Exhibits8: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits9: Parent market
  • Exhibits10: Market Characteristics
  • Exhibits11: Offerings of vendors included in the market definition
  • Exhibits12: Market segments
  • Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits17: Five forces analysis - Comparison between 2021 and 2026
  • Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • Exhibits23: Chart on Market condition - Five forces 2021 and 2026
  • Exhibits24: Chart on Application - Market share 2021-2026 (%)
  • Exhibits25: Data Table on Application - Market share 2021-2026 (%)
  • Exhibits26: Chart on Comparison by Application
  • Exhibits27: Data Table on Comparison by Application
  • Exhibits28: Chart on Obesity - Market size and forecast 2021-2026 ($ million)
  • Exhibits29: Data Table on Obesity - Market size and forecast 2021-2026 ($ million)
  • Exhibits30: Chart on Obesity - Year-over-year growth 2021-2026 (%)
  • Exhibits31: Data Table on Obesity - Year-over-year growth 2021-2026 (%)
  • Exhibits32: Chart on Cardiovascular diseases - Market size and forecast 2021-2026 ($ million)
  • Exhibits33: Data Table on Cardiovascular diseases - Market size and forecast 2021-2026 ($ million)
  • Exhibits34: Chart on Cardiovascular diseases - Year-over-year growth 2021-2026 (%)
  • Exhibits35: Data Table on Cardiovascular diseases - Year-over-year growth 2021-2026 (%)
  • Exhibits36: Chart on Cancer research - Market size and forecast 2021-2026 ($ million)
  • Exhibits37: Data Table on Cancer research - Market size and forecast 2021-2026 ($ million)
  • Exhibits38: Chart on Cancer research - Year-over-year growth 2021-2026 (%)
  • Exhibits39: Data Table on Cancer research - Year-over-year growth 2021-2026 (%)
  • Exhibits40: Market opportunity by Application ($ million)
  • Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits44: Chart on Geographic comparison
  • Exhibits45: Data Table on Geographic comparison
  • Exhibits46: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits48: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits49: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits52: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits56: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
  • Exhibits66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits68: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits70: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits72: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits73: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits74: Chart on France - Market size and forecast 2021-2026 ($ million)
  • Exhibits75: Data Table on France - Market size and forecast 2021-2026 ($ million)
  • Exhibits76: Chart on France - Year-over-year growth 2021-2026 (%)
  • Exhibits77: Data Table on France - Year-over-year growth 2021-2026 (%)
  • Exhibits78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits80: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits82: Market opportunity By Geographical Landscape ($ million)
  • Exhibits83: Impact of drivers and challenges in 2021 and 2026
  • Exhibits84: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits85: Overview on factors of disruption
  • Exhibits86: Impact of key risks on business
  • Exhibits87: Vendors covered
  • Exhibits88: Matrix on vendor position and classification
  • Exhibits89: Cell Logic Pty Ltd - Overview
  • Exhibits90: Cell Logic Pty Ltd - Product / Service
  • Exhibits91: Cell Logic Pty Ltd - Key offerings
  • Exhibits92: Cura Integrative Medicine - Overview
  • Exhibits93: Cura Integrative Medicine - Product / Service
  • Exhibits94: Cura Integrative Medicine - Key offerings
  • Exhibits95: DNA Life - Overview
  • Exhibits96: DNA Life - Product / Service
  • Exhibits97: DNA Life - Key offerings
  • Exhibits98: Fagron NV - Overview
  • Exhibits99: Fagron NV - Business segments
  • Exhibits100: Fagron NV - Key news
  • Exhibits101: Fagron NV - Key offerings
  • Exhibits102: Fagron NV - Segment focus
  • Exhibits103: Genova Diagnostics Inc. - Overview
  • Exhibits104: Genova Diagnostics Inc. - Product / Service
  • Exhibits105: Genova Diagnostics Inc. - Key offerings
  • Exhibits106: Holistic Health International LLC - Overview
  • Exhibits107: Holistic Health International LLC - Product / Service
  • Exhibits108: Holistic Health International LLC - Key offerings
  • Exhibits109: Metagenics Inc. - Overview
  • Exhibits110: Metagenics Inc. - Product / Service
  • Exhibits111: Metagenics Inc. - Key offerings
  • Exhibits112: Nutrigenomix Inc. - Overview
  • Exhibits113: Nutrigenomix Inc. - Product / Service
  • Exhibits114: Nutrigenomix Inc. - Key offerings
  • Exhibits115: The Gene Box - Overview
  • Exhibits116: The Gene Box - Product / Service
  • Exhibits117: The Gene Box - Key offerings
  • Exhibits118: Xcode Life Sciences Pvt. Ltd - Overview
  • Exhibits119: Xcode Life Sciences Pvt. Ltd - Product / Service
  • Exhibits120: Xcode Life Sciences Pvt. Ltd - Key offerings
  • Exhibits121: Inclusions checklist
  • Exhibits122: Exclusions checklist
  • Exhibits123: Currency conversion rates for US$
  • Exhibits124: Research methodology
  • Exhibits125: Validation techniques employed for market sizing
  • Exhibits126: Information sources
  • Exhibits127: List of abbreviations
目次
Product Code: IRTNTR40037

Technavio has been monitoring the nutrigenomics market and it is poised to grow by $ 690.14 mn during 2022-2026, accelerating at a CAGR of 12.4% during the forecast period. Our report on the nutrigenomics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing cost of medical treatment, growing investments by government and private stakeholders, and the rising number of health-conscious people.

The nutrigenomics market analysis includes the application segment and geographic landscape.

Technavio's nutrigenomics market is segmented as below:

By Application

  • Obesity
  • Cardiovascular diseases
  • Cancer research

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the rising demand for training in and awareness of nutrigenomics technologies as one of the prime reasons driving the nutrigenomics market growth during the next few years. Also, increasing approval of grants and increasing prevalence of obesity will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on nutrigenomics market covers the following areas:

  • Nutrigenomics market sizing
  • Nutrigenomics market forecast
  • Nutrigenomics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading nutrigenomics market vendors that include BASF SE, Cell Logic Pty Ltd, Cura Integrative Medicine, DNA Life, Fagron NV, geneOmbio Technologies Pvt Ltd., Genetic Healing, Genova Diagnostics Inc., Greenarray, Holistic Health International LLC, Koninklijke DSM NV, Metagenics Inc., My DNA Health Ltd., NutriFit Canada, Nutrigenomix Inc., ORIG3N Inc., Preventine Life Care, The Gene Box, and Xcode Life Sciences Pvt. Ltd. Also, the nutrigenomics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
  • Exhibit 06: Executive Summary - Chart on Incremental Growth
  • Exhibit 07: Executive Summary - Data Table on Incremental Growth
  • Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 09: Parent market
  • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 12: Market segments
  • 3.3 Market size 2021
  • 3.4 Market outlook: Forecast for 2021-2026
  • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

  • 4.1 Five forces summary
  • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
  • 4.2 Bargaining power of buyers
  • Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • 4.3 Bargaining power of suppliers
  • Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • 4.4 Threat of new entrants
  • Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • 4.5 Threat of substitutes
  • Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • 4.6 Threat of rivalry
  • Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • 4.7 Market condition
  • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Application

  • 5.1 Market segments
  • Exhibit 24: Chart on Application - Market share 2021-2026 (%)
  • Exhibit 25: Data Table on Application - Market share 2021-2026 (%)
  • 5.2 Comparison by Application
  • Exhibit 26: Chart on Comparison by Application
  • Exhibit 27: Data Table on Comparison by Application
  • 5.3 Obesity - Market size and forecast 2021-2026
  • Exhibit 28: Chart on Obesity - Market size and forecast 2021-2026 ($ million)
  • Exhibit 29: Data Table on Obesity - Market size and forecast 2021-2026 ($ million)
  • Exhibit 30: Chart on Obesity - Year-over-year growth 2021-2026 (%)
  • Exhibit 31: Data Table on Obesity - Year-over-year growth 2021-2026 (%)
  • 5.4 Cardiovascular diseases - Market size and forecast 2021-2026
  • Exhibit 32: Chart on Cardiovascular diseases - Market size and forecast 2021-2026 ($ million)
  • Exhibit 33: Data Table on Cardiovascular diseases - Market size and forecast 2021-2026 ($ million)
  • Exhibit 34: Chart on Cardiovascular diseases - Year-over-year growth 2021-2026 (%)
  • Exhibit 35: Data Table on Cardiovascular diseases - Year-over-year growth 2021-2026 (%)
  • 5.5 Cancer research - Market size and forecast 2021-2026
  • Exhibit 36: Chart on Cancer research - Market size and forecast 2021-2026 ($ million)
  • Exhibit 37: Data Table on Cancer research - Market size and forecast 2021-2026 ($ million)
  • Exhibit 38: Chart on Cancer research - Year-over-year growth 2021-2026 (%)
  • Exhibit 39: Data Table on Cancer research - Year-over-year growth 2021-2026 (%)
  • 5.6 Market opportunity by Application
  • Exhibit 40: Market opportunity by Application ($ million)

6 Customer Landscape

  • 6.1 Customer landscape overview
  • Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

  • 7.1 Geographic segmentation
  • Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • 7.2 Geographic comparison
  • Exhibit 44: Chart on Geographic comparison
  • Exhibit 45: Data Table on Geographic comparison
  • 7.3 North America - Market size and forecast 2021-2026
  • Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • 7.4 Europe - Market size and forecast 2021-2026
  • Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • 7.5 Asia - Market size and forecast 2021-2026
  • Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
  • Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • 7.7 US - Market size and forecast 2021-2026
  • Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
  • 7.8 Germany - Market size and forecast 2021-2026
  • Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • 7.9 UK - Market size and forecast 2021-2026
  • Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • 7.10 France - Market size and forecast 2021-2026
  • Exhibit 74: Chart on France - Market size and forecast 2021-2026 ($ million)
  • Exhibit 75: Data Table on France - Market size and forecast 2021-2026 ($ million)
  • Exhibit 76: Chart on France - Year-over-year growth 2021-2026 (%)
  • Exhibit 77: Data Table on France - Year-over-year growth 2021-2026 (%)
  • 7.11 Canada - Market size and forecast 2021-2026
  • Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • 7.12 Market opportunity By Geographical Landscape
  • Exhibit 82: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

  • 8.1 Market drivers
  • 8.2 Market challenges
  • 8.3 Impact of drivers and challenges
  • Exhibit 83: Impact of drivers and challenges in 2021 and 2026
  • 8.4 Market trends

9 Vendor Landscape

  • 9.1 Overview
  • 9.2 Vendor landscape
  • Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
  • 9.3 Landscape disruption
  • Exhibit 85: Overview on factors of disruption
  • 9.4 Industry risks
  • Exhibit 86: Impact of key risks on business

10 Vendor Analysis

  • 10.1 Vendors covered
  • Exhibit 87: Vendors covered
  • 10.2 Market positioning of vendors
  • Exhibit 88: Matrix on vendor position and classification
  • 10.3 Cell Logic Pty Ltd
  • Exhibit 89: Cell Logic Pty Ltd - Overview
  • Exhibit 90: Cell Logic Pty Ltd - Product / Service
  • Exhibit 91: Cell Logic Pty Ltd - Key offerings
  • 10.4 Cura Integrative Medicine
  • Exhibit 92: Cura Integrative Medicine - Overview
  • Exhibit 93: Cura Integrative Medicine - Product / Service
  • Exhibit 94: Cura Integrative Medicine - Key offerings
  • 10.5 DNA Life
  • Exhibit 95: DNA Life - Overview
  • Exhibit 96: DNA Life - Product / Service
  • Exhibit 97: DNA Life - Key offerings
  • 10.6 Fagron NV
  • Exhibit 98: Fagron NV - Overview
  • Exhibit 99: Fagron NV - Business segments
  • Exhibit 100: Fagron NV - Key news
  • Exhibit 101: Fagron NV - Key offerings
  • Exhibit 102: Fagron NV - Segment focus
  • 10.7 Genova Diagnostics Inc.
  • Exhibit 103: Genova Diagnostics Inc. - Overview
  • Exhibit 104: Genova Diagnostics Inc. - Product / Service
  • Exhibit 105: Genova Diagnostics Inc. - Key offerings
  • 10.8 Holistic Health International LLC
  • Exhibit 106: Holistic Health International LLC - Overview
  • Exhibit 107: Holistic Health International LLC - Product / Service
  • Exhibit 108: Holistic Health International LLC - Key offerings
  • 10.9 Metagenics Inc.
  • Exhibit 109: Metagenics Inc. - Overview
  • Exhibit 110: Metagenics Inc. - Product / Service
  • Exhibit 111: Metagenics Inc. - Key offerings
  • 10.10 Nutrigenomix Inc.
  • Exhibit 112: Nutrigenomix Inc. - Overview
  • Exhibit 113: Nutrigenomix Inc. - Product / Service
  • Exhibit 114: Nutrigenomix Inc. - Key offerings
  • 10.11 The Gene Box
  • Exhibit 115: The Gene Box - Overview
  • Exhibit 116: The Gene Box - Product / Service
  • Exhibit 117: The Gene Box - Key offerings
  • 10.12 Xcode Life Sciences Pvt. Ltd
  • Exhibit 118: Xcode Life Sciences Pvt. Ltd - Overview
  • Exhibit 119: Xcode Life Sciences Pvt. Ltd - Product / Service
  • Exhibit 120: Xcode Life Sciences Pvt. Ltd - Key offerings

11 Appendix

  • 11.1 Scope of the report
  • 11.2 Inclusions and exclusions checklist
  • Exhibit 121: Inclusions checklist
  • Exhibit 122: Exclusions checklist
  • 11.3 Currency conversion rates for US$
  • Exhibit 123: Currency conversion rates for US$
  • 11.4 Research methodology
  • Exhibit 124: Research methodology
  • Exhibit 125: Validation techniques employed for market sizing
  • Exhibit 126: Information sources
  • 11.5 List of abbreviations
  • Exhibit 127: List of abbreviations